Caris Life Sciences

Caris Life Sciences is a biotechnology company based in Irving, Texas, specializing in precision medicine and the advancement of oncology treatments. Founded in 1987, the company focuses on developing and commercializing technologies for molecular profiling, anatomic pathology, and blood-based diagnostics across various medical fields, including oncology and pathology. Caris offers comprehensive molecular analyses of patient samples through services such as genomic profiling, transcriptomic and proteomic analysis, and the ADAPT Biotargeting System. Its platform, Caris Molecular Intelligence, aids in providing vital information for personalized treatment decisions by analyzing DNA, RNA, and proteins. The company serves a global market through distributors in the United States, Europe, and Australia, and collaborates strategically with partners like Debiopharm International SA.